K033099 is an FDA 510(k) clearance for the ADR THINSET INFUSION SET MODEL, 23-106, 23-109, 43-106, 43-109. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.
Submitted by Applied Diabetes Research, Incorporated (Laguna Niguel, US). The FDA issued a Cleared decision on October 16, 2003 after a review of 17 days - a notably fast clearance cycle.
This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.